-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence
Andrew J Weickhardt, D Ross Camidge
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation